Regulation of antiviral responses by Ras/MEK

Ras/MEK 调节抗病毒反应

• 批准号: 355606
• 负责人: Hirasawa Kensuke
• 金额: $ 41.8万
• 依托单位: Memorial University of Newfoundland
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2021-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=355606&lang=en
• 关键词: Cancer Therapy; Irf1; Oncolytic Virus; Ras/Mek; Sumoylation; Virology; Virus Infection

Oncolytic viruses are engineered or naturally occurring viruses that replicate in cancer cells, but not in normal cells. They have become a focus of attention for cancer therapy in recent years as clinical studies have shown them to be quite promising. Ho

溶瘤病毒是在癌细胞中复制的工程化或天然存在的病毒， 而不是在正常细胞中。近年来，它们已成为癌症治疗的关注焦点 多年来，临床研究表明它们很有前途。何